Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid tumor in adults which is associated with approximately 30–40 % of all non-Hodgkin’s lymphomas. Diagnostic criteria include diffuse growth of large anaplastic tumor cells, expression of В-cell markers, and a high proliferative index. D...
Main Authors: | SM Rastorguev, DA Koroleva, ES Boulygina, SV Tsygankova, NG Goncharov, OS Naraikin, NG Gabeeva, EE Zvonkov, AV Nedoluzhko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2018-12-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: | http://bloodjournal.ru/wp-content/uploads/2018/12/13-1.pdf |
Similar Items
-
Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling
by: Adrián Mosquera Orgueira, et al.
Published: (2020-10-01) -
Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma
by: Fouad Choueiry, et al.
Published: (2021-04-01) -
The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
by: Hikmat Abdel-Razeq, et al.
Published: (2021-05-01) -
Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma
by: AA Rukavitsyn, et al.
Published: (2017-04-01) -
BRIDGING TO TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA
by: Christian Gisselbrecht, et al.
Published: (2016-07-01)